ctrl K

AI Score

Unlock

Lantern Pharma Inc. (LTRN)

AI Score

Unlock

3.71

-0.24 (-6.08%)

At close: Mar 03, 2025, 3:59 PM

3.71

-0.06%

After-hours: Mar 03, 2025, 04:00 PM EST

Lantern Pharma Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	174.84K	154.68K	97.42K	3.39K	1.63K	-2.54K
Gross Profit	-174.84K	-154.68K	-97.42K	-3.39K	-1.63K	2.54K
Operating Income	-17.88M	-14.43M	-12.59M	-5.91M	-2.43M	-1.73M
Interest Income	765.39K	204.35K	67.93K	n/a	n/a	n/a
Pretax Income	-15.96M	-14.26M	-12.36M	-5.91M	-2.43M	-1.73M
Net Income	-15.96M	-14.09M	-12.3M	-5.91M	-2.43M	-1.73M
Selling & General & Admin	5.98M	5.83M	5.02M	3.66M	1.48M	1.15M
Research & Development	11.89M	8.6M	7.57M	2.24M	953.18K	572.1K
Other Expenses	n/a	-31.55K	160.55K	n/a	n/a	n/a
Operating Expenses	17.88M	14.43M	12.59M	5.91M	2.43M	1.73M
Interest Expense	n/a	204.35K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	17.88M	14.43M	12.59M	5.91M	2.43M	1.73M
Income Tax	n/a	-172.81K	-67.93K	-202.91K	-5	2.54K
Shares Outstanding (Basic)	10.84M	10.85M	10.9M	6.22M	6.27M	6.22M
Shares Outstanding (Diluted)	10.84M	10.85M	10.9M	6.22M	6.27M	6.22M
EPS (Basic)	-1.47	-1.3	-1.13	-0.95	-0.39	-0.28
EPS (Diluted)	-1.47	-1.3	-1.13	-0.95	-0.39	-0.28
EBITDA	-15.79M	-14.42M	-12.27M	-5.9M	-2.43M	-1.73M
Depreciation & Amortization	174.84K	154.68K	97.42K	3.39K	1.63K	-2.54K